Dabigatran etexilate mesylate
Product Intro
Dabigatran mesylate is a direct thrombin inhibitor used in clinic. It is a new oral anticoagulant. Its mechanism is to inhibit the formation of thrombin by reversibly competing for the fibrin specific binding site of thrombin.
Function
Its mechanism is to inhibit the formation of thrombin by reversibly competing for the fibrin specific binding site of thrombin.
Application
Dabigatran mesylate is an API for blood system; Anticoagulant drugs; It can be used to reduce the risk of stroke and systemic embolism in patients with non valvular atrial fibrillation; Dabigatran ester is a new synthetic direct thrombin inhibitor. It is a precursor of dabigatran and a non peptide thrombin inhibitor.
Copyright © Shanghai Norky Pharmaceutical Co., Ltd. All Rights Reserved 沪ICP备20013299号 Powered by www.300.cn